Variant report
Variant | nsv591813 |
---|---|
Chromosome Location | chr3:133133095-133136961 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11711011 | chr3:133133095-133133096 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs552758029 | chr3:133133113-133133114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150193935 | chr3:133133126-133133127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556137734 | chr3:133133139-133133140 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572915371 | chr3:133133160-133133161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11710993 | chr3:133133184-133133185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572628299 | chr3:133133211-133133212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370902299 | chr3:133133232-133133233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559741489 | chr3:133133312-133133313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2699876 | chr3:133133317-133133318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200895323 | chr3:133133320-133133321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555612081 | chr3:133133327-133133328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2699877 | chr3:133133352-133133353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112939005 | chr3:133133408-133133409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564692028 | chr3:133133422-133133423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575602145 | chr3:133133468-133133469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544566984 | chr3:133133487-133133488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs193204202 | chr3:133133493-133133494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113300346 | chr3:133133553-133133554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs80073401 | chr3:133133559-133133560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75619310 | chr3:133133561-133133562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7372238 | chr3:133133564-133133565 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs371343491 | chr3:133133582-133133583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368745342 | chr3:133133583-133133584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372803425 | chr3:133133584-133133585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114051217 | chr3:133133585-133133586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540640182 | chr3:133133589-133133590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560335850 | chr3:133133594-133133595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7372239 | chr3:133133621-133133622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550349642 | chr3:133133629-133133630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs148531613 | chr3:133133631-133133632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs55987733 | chr3:133133638-133133639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529395038 | chr3:133133654-133133655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372041023 | chr3:133133655-133133656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566105882 | chr3:133133663-133133664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565699651 | chr3:133133664-133133665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534311165 | chr3:133133667-133133668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562786482 | chr3:133133670-133133671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139835364 | chr3:133133697-133133698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145368640 | chr3:133133712-133133713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551690064 | chr3:133133718-133133719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571622556 | chr3:133133721-133133722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150635727 | chr3:133133722-133133723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs386666046 | chr3:133133730-133133731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200313229 | chr3:133133789-133133790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368741249 | chr3:133133799-133133800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184726391 | chr3:133133804-133133805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111779197 | chr3:133133811-133133812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs202242051 | chr3:133133824-133133825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112124504 | chr3:133133826-133133827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Hailey-hailey disease | 17597066 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Lung cancer | 16740712 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:133124600-133138400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr3:133131400-133133200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr3:133132000-133133200 | Enhancers | Fetal Stomach | stomach |
4 | chr3:133132800-133133200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr3:133132800-133133200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
6 | chr3:133133000-133133200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr3:133133000-133140600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr3:133134400-133135200 | Active TSS | Spleen | Spleen |